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We have monitored molecular interactions of sarcolipin (SLN) and the sarco-
plasmic reticulum Ca-ATPase (SERCA) by measuring Fo¨rster resonance en-
ergy transfer (FRET) between fusion proteins labeled with cyan fluorescent
protein (CFP) and yellow fluorescent protein (YFP). SLN regulates contractil-
ity in cardiac and skeletal muscle by regulating SERCA calcium uptake and
perhaps by acting as an ion channel. Here, live cell FRET microscopy provided
novel evidence for self-association of SLN and for regulatory complex forma-
tion between SERCA and SLN. Fluorescence photobleaching revealed that
SLN self-assembles into dimers but not higher oligomers, and that SERCA
and SLN monomers bind together in a 1:1 binary complex. FRET between
CFP-SLN:YFP-SLN and CFP-SERCA:YFP-SLN exhibited a hyperbolic de-
pendence on protein concentration, with maximum efficiency of 62 5 1%
and 52 5 1%, respectively. The concentration of half-maximal FRET was
7.65 0.4 AU for SLN:SLN and 17.05 1.0 AU for SERCA:SLN, demonstrat-
ing that the binding affinity of SLN:SLN homo-dimers is 2.2-fold greater than
SERCA:SLN hetero-dimers. Mutating SLN residue Ile-17 to Ala (I17A) de-
creased maximum FRET for SERCA:SLN by 145 4% with no change in bind-
ing affinity, indicating that the I17A-SLN mutation causes a structural rear-
rangement with distance increase of 5 5 1 A˚ within the binary regulatory
complex. Addition of wild-type SERCA (cardiac and fast-twitch isoforms) de-
creased the binding affinity of the SLN:SLN interaction by 245 6% with no
change in maximum FRET, indicating that SLN monomers are in competition
between dimerization and SERCA binding. We propose that SLN exists as
monomers, homo-dimers, and hetero-dimers in sarcoplasmic reticulum mem-
branes, and that Ile-17 of SLN acts as an allosteric switch in the regulatory com-
plex with SERCA.
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High-affinity Ca2þ-transport ATPases are key components in the machinery of
cytosolic Ca2þ regulation. We have found that the Ca2þ-dependence of plasma
membrane Ca2þ-ATPase (PMCA) activity is constant between pCa values of
6.5 and 4.5 in membranes from Alzheimer’s disease (AD) affected-brain
whereas in normal brain the activity increases from pCa 6.5 to 5.5 and then de-
creases from 5.5 to 4.5. However, the Ca2þ-dependencies of sarco(endo)plas-
mic- (SERCA) and secretory pathway- (SPCA) Ca2þ-ATPases activity are sim-
ilar in AD and normal brains. Addition of amyloid b-peptide (Ab) to normal
brain decreases the activity of PMCA at pCa 5.5, resulting in the same Ca2þ-
dependence as that seen in AD brain, whereas addition of Ab to AD membranes
has no effect on PMCA activity. Ab also decreases the activity of PMCA pu-
rified from pig cerebrum, the effect being isoform specific, with greatest inhi-
bition for PMCA4, smaller inhibition for PMCA3 and no inhibition for
PMCA2. The effect of peptide on PMCA was also seen in primary culture of
mouse hippocampal neurons, and the lack of effect on the other pumps was
seen on SERCA and SPCA from cultured neurons and on SERCA1 from rabbit
skeletal muscle and on SERCA2a and SERCA2b overexpressed in COS cells.
Besides, cholesterol blocked the inhibitory effect of Ab on PMCA in different
model systems and in the raft fraction of pig synaptosomal membranes. From
these data we can conclude that impairment of PMCA functioning with respect
to Ca2þ is closely linked to the presence of amyloid-b peptide in AD brain.
This work was supported by Grants from MICINN (BFU2008-00182) and Fun-
dacio´n Marcelino Botı´n, Spain.
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The sarco(endo)plasmic Ca-ATPase (SERCA2a) sequesters Ca2þ ions from
the cytosol into the cardiac sarcoplasmic reticulum (CSR) to promote cardiac
relaxation. Phospholamban (PLN) is an integral membrane protein that regu-
lates SERCA2a in CSR. Phosphorylation of PLN in response to b-adrenergicstimulation enhances cardiac inotropy by increasing CSR Ca2þ uptake. Ni-
troxyl (HNO), a new candidate drug therapy for congestive heart failure
(CHF), improves overall cardiovascular function by increasing Ca2þ release
and Ca2þ re-uptake in CSR through direct effects on RyR2 and SERCA2a, re-
spectively. We propose that HNO, a thiol oxidant, modifies one or more PLN
sulfhydryls and thereby decreases the regulatory interaction of PLN with SER-
CA2a, contributing to SERCA2a activation. To test this model, we have used
fluorescence and EPR spectroscopy to determine the effects of HNO on the
physical regulation of SERCA2a by PLN. We used expressed SERCA2a 5
coexpressed PLN in High Five insect cells microsomes and Angeli’s Salt
(AS) as our HNO donor. Steady-state fluorescence intensity studies of
FITC-labeled SERCA2a coexpressed with PLN showed that AS/HNO in-
creased the amplitude of the Ca2þ-dependent E2 to E1Ca2 conformational
change by nearly two fold, similar to the effect observed when PLN is un-
coupled from SERCA2a by anti-PLN antibody treatment. This matches our
previous finding that AS/HNO stimulates SERCA2a activity nearly two
fold. Saturation-transfer EPR studies of maleimide spin-labeled SERCA2a
coexpressed with PLN showed that AS/HNO decreased the rotational mobility
of SERCA2a, but not significantly more than that of control SERCA2a without
PLN. Taken together, our results suggest HNO physically uncouples PLN
from SERCA2a increasing SERCA2a conformational flexibility and SER-
CA2a activity. We are investigating the role of individual PLN cysteines in
this mechanism by repeating these experiments using SERCA2a coexpressed
with PLN cysteine mutants, and direct effects of HNO on SERCA2a are also
being investigated.
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We used time-resolved fluorescence resonance energy transfer (TR-FRET) to
determine the oligomeric state of phospholamban (PLB) and its inhibited tar-
get, sarcoplasmic reticulum Ca-ATPase (SERCA). Previous work on our lab
has shown that PLB is primarily pentameric but SERCA binds preferentially
to the monomeric form in lipid vesicles. Recent EM studies suggest that the
PLB pentamer might also bind to SERCA. We tested this hypothesis by label-
ing SERCA at C674 with a fluorescent donor (TMRIA) and labeling PLB at K3
with a non-fluorescent acceptor (MGITC), then reconstituting the proteins into
lipid vesicles and performing TR-FRET as a function of the fraction of accep-
tor-labeled PLB (xA), keeping the total PLB/SERCA molar ratio constant at 10.
Simulations showed that if a PLB monomer binds to SERCA, the dependence
of FRET on xA should be linear, but the binding of a PLB oligomer should pro-
duce distinct curvature in the plot. The observed plot was quite linear, and was
indistinguishable from control experiments using a monomeric mutant of PLB.
We conclude that PLB binds to SERCA only as a monomer. These results have
important implications for the design of PLB mutants to be used in gene therapy
for heart failure.
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We are using solid-phase peptide synthesis, membrane reconstitution, an en-
zyme-coupled Ca-ATPase activity assay, and time-resolved fluorescence reso-
nance energy transfer (TR-FRET) to investigate the molecular mechanism by
which the cardiac Ca-ATPase (SERCA) is regulated by phospholamban
(PLB). In human heart failure, SERCA activity is inadequate, and current ther-
apeutic research focuses on the goal of increasing SERCA activity by reducing
PLB inhibition of SERCA. PLB inhibition is relieved by [Ca2þ] > mM or by
phosphorylation of S16 by PKA. It has been proposed that relief of this inhibi-
tion requires dissociation of the SERCA-PLB complex. To test this hypothesis,
we have designed and synthesized monomeric PLB variants with a FRET ac-
ceptor (DABCYL), with and without phosphorylation at S16, and then recon-
stituted them with SERCA labeled with a FRET donor (IAEDANS). After re-
constitution, the interactions of these PLB variants with SERCA were
characterized both functionally (Ca-ATPase activity) and physically (TR-
FRET), as affected by Ca2þ and PLB phosphorylation. We found that Ca2þ
completely relieves SERCA inhibition, while phosphorylation partially re-
lieves SERCA inhibition. We also found that Ca2þ and phosphorylation have
slight but opposite effects on FRET. Time resolution provided independent
measurements of protein association and structure. We conclude that inhibition
of SERCA is relieved by structural rearrangement within the SERCA-PLB
complex, without dissociation of PLB from SERCA, with distinct mechanisms
for relief by Ca2þ and PLB phosphorylation.
